Candel Therapeutics, Inc. CADL Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s shares (basic)?
- Candel Therapeutics, Inc. (CADL) reported shares (basic) of 62.4M in Q1 2026.
- How has Candel Therapeutics, Inc.'s shares (basic) changed year-over-year?
- Candel Therapeutics, Inc.'s shares (basic) increased by 23.5% year-over-year, from 50.5M to 62.4M.
- What is the long-term trend for Candel Therapeutics, Inc.'s shares (basic)?
- Over 3 years (2022 to 2025), Candel Therapeutics, Inc.'s shares (basic) has grown at a 22.1% compound annual growth rate (CAGR), from 115.2M to 209.8M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.